164 related articles for article (PubMed ID: 31828511)
61. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
[TBL] [Abstract][Full Text] [Related]
62. The regulation of HIV-1 gene expression: the emerging role of chromatin.
He G; Ylisastigui L; Margolis DM
DNA Cell Biol; 2002 Oct; 21(10):697-705. PubMed ID: 12443539
[TBL] [Abstract][Full Text] [Related]
63. Two long terminal repeat circles and persistent HIV-1 replication.
Sharkey ME; Stevenson M
Curr Opin Infect Dis; 2001 Feb; 14(1):5-11. PubMed ID: 11979108
[TBL] [Abstract][Full Text] [Related]
64. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.
Buzón MJ; Massanella M; Llibre JM; Esteve A; Dahl V; Puertas MC; Gatell JM; Domingo P; Paredes R; Sharkey M; Palmer S; Stevenson M; Clotet B; Blanco J; Martinez-Picado J
Nat Med; 2010 Apr; 16(4):460-5. PubMed ID: 20228817
[TBL] [Abstract][Full Text] [Related]
65. Regulation of HIV-1 latency by chromatin structure and nuclear architecture.
Lusic M; Giacca M
J Mol Biol; 2015 Feb; 427(3):688-94. PubMed ID: 25073101
[TBL] [Abstract][Full Text] [Related]
66. Impact of T cell activation, HIV replication and hepatitis C virus infection on neutrophil CD64 expression.
Morquin D; Tuaillon E; Makinson A; Bendriss S; Le Moing V; Reynes J
Cytometry B Clin Cytom; 2017 Nov; 92(6):492-497. PubMed ID: 27221825
[TBL] [Abstract][Full Text] [Related]
67. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.
Redel L; Le Douce V; Cherrier T; Marban C; Janossy A; Aunis D; Van Lint C; Rohr O; Schwartz C
J Leukoc Biol; 2010 Apr; 87(4):575-88. PubMed ID: 19801499
[TBL] [Abstract][Full Text] [Related]
68. HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes.
Ryckman C; Robichaud GA; Roy J; Cantin R; Tremblay MJ; Tessier PA
J Immunol; 2002 Sep; 169(6):3307-13. PubMed ID: 12218151
[TBL] [Abstract][Full Text] [Related]
69. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
70. Epigenetic regulation of HIV-1 persistence and evolving strategies for virus eradication.
Dhamija N; Rawat P; Mitra D
Subcell Biochem; 2013; 61():479-505. PubMed ID: 23150264
[TBL] [Abstract][Full Text] [Related]
71. Nuclear RNA surveillance complexes silence HIV-1 transcription.
Contreras X; Salifou K; Sanchez G; Helsmoortel M; Beyne E; Bluy L; Pelletier S; Rousset E; Rouquier S; Kiernan R
PLoS Pathog; 2018 Mar; 14(3):e1006950. PubMed ID: 29554134
[TBL] [Abstract][Full Text] [Related]
72. Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.
Shah S; Nonnemacher MR; Pirrone V; Wigdahl B
J Neuroimmune Pharmacol; 2010 Sep; 5(3):278-93. PubMed ID: 20387125
[TBL] [Abstract][Full Text] [Related]
73. BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.
Cismasiu VB; Ghanta S; Duque J; Albu DI; Chen HM; Kasturi R; Avram D
Blood; 2006 Oct; 108(8):2695-702. PubMed ID: 16809611
[TBL] [Abstract][Full Text] [Related]
74. Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells.
Zhang M; Clausell A; Robinson T; Yin J; Chen E; Johnson L; Weiss G; Sabbaj S; Lowe RM; Wagner FH; Goepfert PA; Kutsch O; Cron RQ
J Immunol; 2012 Sep; 189(6):2746-57. PubMed ID: 22875803
[TBL] [Abstract][Full Text] [Related]
75. Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b.
Sidwell T; Rothenberg EV
Front Immunol; 2021; 12():669498. PubMed ID: 33936112
[TBL] [Abstract][Full Text] [Related]
76. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
Front Immunol; 2022; 13():985280. PubMed ID: 36211334
[TBL] [Abstract][Full Text] [Related]
77. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
[TBL] [Abstract][Full Text] [Related]
78. The BAF complex and HIV latency.
Mahmoudi T
Transcription; 2012; 3(4):171-6. PubMed ID: 22771990
[TBL] [Abstract][Full Text] [Related]
79. Cell type-specific actions of Bcl11b in early T-lineage and group 2 innate lymphoid cells.
Hosokawa H; Romero-Wolf M; Yang Q; Motomura Y; Levanon D; Groner Y; Moro K; Tanaka T; Rothenberg EV
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31653691
[TBL] [Abstract][Full Text] [Related]
80. A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.
Goos JAC; Vogel WK; Mlcochova H; Millard CJ; Esfandiari E; Selman WH; Calpena E; Koelling N; Carpenter EL; Swagemakers SMA; van der Spek PJ; Filtz TM; Schwabe JWR; Iwaniec UT; Mathijssen IMJ; Leid M; Twigg SRF
Hum Mol Genet; 2019 Aug; 28(15):2501-2513. PubMed ID: 31067316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
